What a great move on ok PR
$Processa Pharmaceuticals(PCSA.US$ Processa Pharmaceuticals Announces Completion Of Phase 1b Safety Evaluation Of NGC-Cap In Patients With Advanced Cancer Resulting In Recommended Phase 2 Doses![]()
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
MangoXXXX : 4 dollars ??
TrytosaveabitOP MangoXXXX: With the correct volume! Top I would think is 4.22? If it makes that I will reassess! GL